The Medical Letter on Drugs and Therapeutics
FROM
ISSUE921
ISSUE921
April 29, 1994
Salmeterol
Subscribers: Log in to read full article. Not a subscriber? Subscribe or purchase article. |
Salmeterol
April 29, 1994 (Issue: 921)
Salmeterol xinafoate (Serevent - Allen & Hanburys), a long-acting β 2 -selective adrenergic agonist for inhalation, has been approved by the US Food and Drug Administration for maintenance treatment of asthma, with or without concurrent use of...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.